HKSE · 8049.HK · HKD
Stock price, dividends, earnings
Quote as of Oct 27, 2026, 06:04 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
Jilin Province Huinan Changlong Bio-pharmacy Company Limited’s quoted price sits in the upper half of its reported 52-week range, 10.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Jilin Province Huinan Changlong Bio-pharmacy Company Limited’s forward annual dividend is HK$0.08 per share, paid annual. The forward yield is 2.95% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Jilin Province Huinan Changlong Bio-pharmacy Company Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Jilin Province Huinan Changlong Bio-pharmacy Company Limited focuses on the manufacturing and sale of traditional Chinese medicines and various pharmaceutical products within the People's Republic of China. The company's extensive product portfolio includes a wide range of dosage forms such as tablets, capsules, and pills, as well as specialized items like Chinese medicine pretreatment and extraction products. They also provide various injectable solutions, including powders for injection, lyophilized powders for injection, and small volume liquid injections, along with active pharmaceutical ingredients (APIs) and granules. These products are primarily sold under the "Changlong" and "Qing Tong" brand names. Established in 1989, and headquartered in Kowloon, Hong Kong, the company was previously known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:13 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
HK$1.17+HK$0.03 (+2.18%)
China Traditional Chinese Medicine Holdings Co. Limited’s quoted price sits in the lower half of its reported 52-week range, 51.25% below the high.
HK$7.52+HK$0.24 (+3.3%)
China Shineway Pharmaceutical Group Limited’s quoted price sits in the lower half of its reported 52-week range, 28.18% below the high.
HK$5.65+HK$0.12 (+2.08%)
Beijing Tong Ren Tang Chinese Medicine Company Limited’s quoted price sits in the lower half of its reported 52-week range, 40.53% below the high.
HK$3.00+HK$0.09 (+2.92%)
Tong Ren Tang Technologies Co. Ltd.’s quoted price sits in the lower half of its reported 52-week range, 39.49% below the high.
HK$1.96+HK$0.01 (+0.51%)
Golden Throat Holdings Group Company Limited’s quoted price sits in the lower half of its reported 52-week range, 48.42% below the high.
HK$0.98-HK$0.02 (-2.0%)
Fusen Pharmaceutical Company Limited’s quoted price sits in the lower half of its reported 52-week range, 31.94% below the high.
HK$0.63-HK$0.01 (-1.56%)
Zhongzhi Pharmaceutical Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 35.71% below the high.
HK$0.38+HK$0.04 (+10.29%)
Wai Yuen Tong Medicine Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 23.47% below the high.
